Financial Tearsheet






Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

18 Sep 23
Cronos launches leading medical brand PEACE NATURALS® in Germany
TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it shipped its first order of bulk cannabis, which will be sold under the PEACE NATURALS® brand in Germany. In July, Cronos signed a distribution agreement with
08 Aug 23
Cronos Group Reports 2023 Second Quarter Results
Industry-leading balance sheet with $841 million in cash and short-term investments Increased 2023 operating expense savings target to $20 to $25 million Announces additional initiatives to streamline supply chain and improve cash flow Spinach ® was top-10 in retail sales in every category it
20 Jul 23
Cronos Group Inc. to Hold 2023 Second Quarter Earnings Conference Call on August 8, 2023
TORONTO, July 20, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 second quarter earnings conference call on Tuesday, August 8, 2023 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and

SEC Filings

Filing date Description

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Events

08 August 2023 at 8:30 AM EDT
Cronos Group Second Quarter 2023 Earnings Conference Call
22 June 2023 at 11:00 AM EDT
2023 Annual Meeting of Shareholders
01 June 2023 at 1:30 PM EDT
Bernstein's 39th Annual Strategic Decisions Conference